Although a recent work reported that TET2 augments the IFN-gamma-induced PD-L1 expression in melanoma, colon cancer, and acute monocytic leukemia cells [15], whether TET2 is involved in the epigenetic regulation of PD-L1 gene expression in breast cancer remains largely unknown. Here, IFNG is linked to breast carcinoma.